NDC 51662-1335

DILTIAZEM HCI

Diltiazem Hci

DILTIAZEM HCI is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Diltiazem Hydrochloride.

Product ID51662-1335_7d8e8b1e-f67c-57d2-e053-2991aa0a8d12
NDC51662-1335
Product TypeHuman Prescription Drug
Proprietary NameDILTIAZEM HCI
Generic NameDiltiazem Hci
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-12-21
Marketing CategoryANDA / ANDA
Application NumberANDA078538
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameDILTIAZEM HYDROCHLORIDE
Active Ingredient Strength5 mg/mL
Pharm ClassesCalcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51662-1335-1

5 mL in 1 VIAL (51662-1335-1)
Marketing Start Date2018-12-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51662-1335-1 [51662133501]

DILTIAZEM HCI INJECTION
Marketing CategoryANDA
Application NumberANDA078538
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-12-21
Inactivation Date2020-01-31
Reactivation Date2020-02-07

Drug Details

Active Ingredients

IngredientStrength
DILTIAZEM HYDROCHLORIDE5 mg/mL

OpenFDA Data

SPL SET ID:7d8e8b1e-f67b-57d2-e053-2991aa0a8d12
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1791229
  • Pharmacological Class

    • Calcium Channel Antagonists [MoA]
    • Calcium Channel Blocker [EPC]

    NDC Crossover Matching brand name "DILTIAZEM HCI" or generic name "Diltiazem Hci"

    NDCBrand NameGeneric Name
    51662-1335DILTIAZEM HCIDILTIAZEM HCI
    51662-1457DILTIAZEM HCIDILTIAZEM HCI

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.